149 related articles for article (PubMed ID: 35134836)
1. Sustained expression of HPV16 E7 oncoprotein promotes p-AKT(Ser473)/p-Src(Tyr527) signaling to drive precancerous lesions to invasive cervical cancer.
Lin Z; Zhao Y; Li Q; Ci X; Ye X; Chen G; Tu Q; Feng W; Jiang P; Zhu S; Xue X; Saunders NA; Zhang L; Zhu X; Zhao KN
Carcinogenesis; 2022 Jun; 43(5):479-493. PubMed ID: 35134836
[TBL] [Abstract][Full Text] [Related]
2. Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.
Trejo-Cerro O; Massimi P; Broniarczyk J; Myers M; Banks L
J Virol; 2022 Oct; 96(20):e0122922. PubMed ID: 36197110
[TBL] [Abstract][Full Text] [Related]
3. ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.
Nouel J; White EA
mBio; 2022 Dec; 13(6):e0203322. PubMed ID: 36346242
[TBL] [Abstract][Full Text] [Related]
4. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.
Baldwin A; Huh KW; Münger K
J Virol; 2006 Jul; 80(13):6669-77. PubMed ID: 16775354
[TBL] [Abstract][Full Text] [Related]
6. Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.
Szalmás A; Gyöngyösi E; Ferenczi A; László B; Karosi T; Csomor P; Gergely L; Veress G; Kónya J
Virol J; 2013 Mar; 10():79. PubMed ID: 23497302
[TBL] [Abstract][Full Text] [Related]
7. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
10. Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein.
Lee SA; Ho C; Troxler M; Lin CY; Chung SH
Viruses; 2021 Mar; 13(3):. PubMed ID: 33800513
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
12. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
13. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
Hu R; Dong Z; Zhang K; Pan G; Li C; Cui H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204370
[TBL] [Abstract][Full Text] [Related]
14. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
[TBL] [Abstract][Full Text] [Related]
15. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
16. MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2.
Sinha A; Ghosh A; Ghosh A; Mathai S; Bhaumik J; Mukhopadhyay A; Maitra A; Biswas NK; Sengupta S
Clin Epigenetics; 2024 Mar; 16(1):40. PubMed ID: 38461243
[TBL] [Abstract][Full Text] [Related]
17. The application of CRISPR/Cas9 system in cervical carcinogenesis.
Gao C; Wu P; Yu L; Liu L; Liu H; Tan X; Wang L; Huang X; Wang H
Cancer Gene Ther; 2022 May; 29(5):466-474. PubMed ID: 34349239
[TBL] [Abstract][Full Text] [Related]
18. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical Cancer Cells.
Tian S; Zhang L; Li Y; Cao D; Quan S; Guo Y; Yang X; Yang T
Anticancer Agents Med Chem; 2021; 21(13):1689-1696. PubMed ID: 33155930
[TBL] [Abstract][Full Text] [Related]
20. p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling.
Srivastava K; Pickard A; McDade S; McCance DJ
Oncotarget; 2017 Mar; 8(10):16202-16219. PubMed ID: 26001294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]